Factoring in API business’ spinoff + a strong Q1
-"We have updated our model to incorporate the impact of the spin-off of the API (active pharmaceutical ingredient) business, which had listed separately as EUROAPI – now part of the NAV as an equity ..."
You may also be interested by these reports :
However, these expenses are investment into growth and should continue to support Astra’s sector-leading top-line growth in the coming years. ...
Roadshow highlights: CFO Suter shows himself very confident to reach Siegfried’s 2022E guidance and mid-term targets
Sentiment for the current business environment might be far better than expected by many market participants, but question mark on the development ...
We have revised downwards our profitability expectations due to the significant price increases for consumables and single-use products. Compounded ...